{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:54:02Z","timestamp":1774896842870,"version":"3.50.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Syst. Biol."],"abstract":"<jats:p>Prioritizing actionable drug targets is a critical challenge in cancer research, where high-dimensional genomic data and the complexity of tumor biology often hinder effective prioritization. To address this, we developed GETgene-AI, a novel computational framework that integrates network-based prioritization, machine learning, and automated literature analysis to prioritize and rank potential therapeutic targets. Central to GETgene-AI is the G.E.T. strategy, which combines three data streams: mutational frequency (G List), differential expression (E List), and known drug targets (T List). These components are iteratively refined and ranked using the Biological Entity Expansion and Ranking Engine (BEERE), leveraging protein-protein interaction networks, functional annotations, and experimental evidence. Additionally, GETgene-AI incorporates GPT-4o, an advanced large language model, to automate literature-based ranking, reducing manual curation and increasing efficiency. In this study, we applied GETgene-AI to pancreatic cancer as a case study. The framework successfully prioritized high-priority targets such as PIK3CA and PRKCA, validated through experimental evidence and clinical relevance. Benchmarking against GEO2R and STRING demonstrated GETgene-AI\u2019s superior performance, achieving higher precision, recall, and efficiency in prioritizing actionable targets. Moreover, the framework mitigated false positives by deprioritizing genes lacking functional or clinical significance. While demonstrated on pancreatic cancer, the modular design of GETgene-AI enables scalability across diverse cancers and diseases. By integrating multi-omics datasets with advanced computational and AI-driven approaches, GETgene-AI provides a versatile and robust platform for accelerating cancer drug discovery. This framework bridges computational innovations with translational research to improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fsysb.2025.1649758","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:14:11Z","timestamp":1759119251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["GETgene-AI: a framework for prioritizing actionable cancer drug targets"],"prefix":"10.3389","volume":"5","author":[{"given":"Adrian","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/antiox12030573","article-title":"A meta-analysis study to infer voltage-gated K+ Channels prognostic value in different cancer types","volume":"12","author":"Angi","year":"2023","journal-title":"Antioxid. Basel Switz."},{"key":"B3","doi-asserted-by":"publisher","first-page":"v11","DOI":"10.1093\/annonc\/mdz238.036","article-title":"Adaption of pancreatic cancer cells to AKT1 inhibition induces the acquisition of cancer stem-cell like phenotype through upregulation of mitochondrial functions","volume":"30","author":"Arasanz","year":"2019","journal-title":"Ann. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1208\/s12248-012-9447-1","article-title":"Strategic applications of gene expression: from drug discovery\/development to bedside","volume":"15","author":"Bai","year":"2013","journal-title":"AAPS J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10555-021-09990-2","article-title":"Targeting KRAS in pancreatic cancer: new drugs on the horizon","volume":"40","author":"Bannoura","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2300252","DOI":"10.1200\/PO.23.00252","article-title":"Exceptional responses to selpercatinib in RET fusion-driven metastatic pancreatic cancer","volume":"7","author":"Bhamidipati","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3390\/ijms20143500","article-title":"Beyond TCR signaling: emerging functions of lck in cancer and immunotherapy","volume":"20","author":"Bommhardt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12859-019-3036-6","article-title":"Measuring rank robustness in scored protein interaction networks","volume":"20","author":"Bozhilova","year":"2019","journal-title":"BMC Bioinforma."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/ijc.29590","article-title":"TERT gene harbors multiple variants associated with pancreatic cancer susceptibility","volume":"137","author":"Campa","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccell.2020.12.008","article-title":"Targeting pan-essential genes in cancer: challenges and opportunities","volume":"39","author":"Chang","year":"2021","journal-title":"Cancer Cell"},{"key":"B14","first-page":"367","article-title":"Mining Alzheimer disease relevant proteins from integrated protein interactome data","author":"Chen","year":"2006","journal-title":"Pac. Symp. Biocomput. Pac. Symp. Biocomput."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1186\/1471-2164-10-S1-S16","article-title":"HAPPI: an online database of comprehensive human annotated and predicted protein interactions","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Genomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/clpt.2013.195","article-title":"Network medicine: finding the links to personalized therapy","volume":"94","author":"Chen","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12864-017-3512-1","article-title":"HAPPI-2: a comprehensive and high-quality map of human annotated and predicted protein interactions","volume":"18","author":"Chen","year":"2017","journal-title":"BMC Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7150\/ijms.5547","article-title":"Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis","volume":"10","author":"Cheng","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2105-10-S11-S5","article-title":"HPD: an online integrated human pathway database enabling systems biology studies","volume":"10","author":"Chowbina","year":"2009","journal-title":"BMC Bioinforma."},{"key":"B20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/gutjnl-2018-316822","article-title":"Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine","volume":"68","author":"Conway","year":"2019","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/bioinformatics\/btz815","article-title":"PRODIGY: personalized prioritization of driver genes","volume":"36","author":"Dinstag","year":"2020","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/cancers13246354","article-title":"DNA methylation of PI3K\/AKT pathway-related genes predicts outcome in patients with pancreatic cancer: a comprehensive bioinformatics-based study","volume":"13","author":"Faleiro","year":"2021","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.09.527562","article-title":"Prioritizing complex disease genes from heterogeneous public databases","author":"Gong","year":"2023"},{"key":"B25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/biomedicines8100379","article-title":"Vav1 down-modulates Akt2 expression in cells from pancreatic ductal adenocarcinoma: nuclear Vav1 as a potential regulator of akt related malignancy in pancreatic cancer","volume":"8","author":"Grassilli","year":"2020","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/genes14071346","article-title":"Therapeutic targeting of DNA replication stress in cancer","volume":"14","author":"Gu","year":"2023","journal-title":"Genes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41575-021-00463-z","article-title":"The pancreatic cancer genome revisited","volume":"18","author":"Hayashi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-540-71279-4_19","article-title":"Src kinase and pancreatic cancer","volume-title":"Pancreatic cancer","author":"Hilbig","year":"2008"},{"key":"B29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1535-6108(03)00309-x","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e29210","DOI":"10.1016\/j.heliyon.2024.e29210","article-title":"MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells","volume":"10","author":"Hu","year":"2024","journal-title":"Heliyon"},{"key":"B32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1517\/17460441003725102","article-title":"Systems biology visualization tools for drug target discovery","volume":"5","author":"Huan","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1186\/1471-2164-13-S6-S17","article-title":"C\u00b2Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships","volume":"13","author":"Huang","year":"","journal-title":"BMC Genomics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2105-13-S15-S2","article-title":"PAGED: a pathway and gene-set enrichment database to enable molecular phenotype discoveries","volume":"13","author":"Huang","year":"","journal-title":"BMC Bioinforma."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-16-S13-S4","article-title":"DMAP: a connectivity map database to enable identification of novel drug repositioning candidates","volume":"16","author":"Huang","year":"2015","journal-title":"BMC Bioinforma."},{"key":"B36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/gutjnl-2019-320441","article-title":"CDK1\/2\/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer","volume":"70","author":"Huang","year":"2021","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3934\/mbe.2021147","article-title":"Network diffusion with centrality measures to identify disease-related genes","volume":"18","author":"Janyasupab","year":"2021","journal-title":"Math. Biosci. Eng."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.3892\/ol.2019.10812","article-title":"HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma","volume":"18","author":"Jiang","year":"2019","journal-title":"Oncol. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jrsm.1715","article-title":"Can large language models replace humans in systematic reviews? Evaluating GPT-4\u2019s efficacy in screening and extracting data from peer-reviewed and grey literature in multiple languages","volume":"15","author":"Khraisha","year":"2024","journal-title":"Res. Synth. Methods"},{"key":"B44","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open Targets: a platform for therapeutic target identification and validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/mp.2013.184","article-title":"P-values in genomics: apparent precision masks high uncertainty","volume":"19","author":"Lazzeroni","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1504\/IJDMB.2010.033519","article-title":"Discovering breast cancer drug candidates from biomedical literature","volume":"4","author":"Li","year":"2010","journal-title":"Int. J. Data Min. Bioinforma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1691\/ph.2022.1881","article-title":"ARID1A promotes chemosensitivity to gemcitabine in pancreatic cancer through epigenetic silencing of RRM2","volume":"77","author":"Li","year":"2022","journal-title":"Pharm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/cancers11081087","article-title":"Novel apoptosis-inducing agents for the treatment of cancer, a new arsenal in the toolbox","volume":"11","author":"Lim","year":"2019","journal-title":"Cancers"},{"key":"B50","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nrd1202","article-title":"Target discovery","volume":"2","author":"Lindsay","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"B51","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/mc.23208","article-title":"Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer","volume":"59","author":"Liu","year":"2020","journal-title":"Mol. Carcinog."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.drudis.2021.06.009","article-title":"AI-based language models powering drug discovery and development","volume":"26","author":"Liu","year":"2021","journal-title":"Drug Discov. Today"},{"key":"B53","doi-asserted-by":"publisher","first-page":"16679","DOI":"10.1038\/s41598-018-35149-1","article-title":"Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis","volume":"8","author":"L\u00f3pez-Cort\u00e9s","year":"2018","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1002690","DOI":"10.1371\/journal.pcbi.1002690","article-title":"Enhancing the prioritization of disease-causing genes through tissue specific protein interaction networks","volume":"8","author":"Magger","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","article-title":"Testing significance relative to a fold-change threshold is a TREAT","volume":"25","author":"McCarthy","year":"2009","journal-title":"Oxf. Engl."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13059-021-02504-x","article-title":"Network propagation-based prioritization of long tail genes in 17 cancer types","volume":"22","author":"Mohsen","year":"2021","journal-title":"Genome Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2105-3-17","article-title":"The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data","volume":"3","author":"Mutch","year":"2002","journal-title":"BMC Bioinforma."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10738","DOI":"10.1038\/s41598-024-61124-0","article-title":"Emerging opportunities of using large language models for translation between drug molecules and indications","volume":"14","author":"Oniani","year":"2024","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/bib\/bbz122","article-title":"An omics perspective on drug target discovery platforms","volume":"21","author":"Paananen","year":"2020","journal-title":"Brief. Bioinform."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1038\/oncsis.2015.28","article-title":"PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors","volume":"4","author":"Payne","year":"2015","journal-title":"Oncogenesis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbadis.2017.10.019","article-title":"TOP2A induces malignant character of pancreatic cancer through activating \u03b2-catenin signaling pathway","volume":"1864","author":"Pei","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1109\/TCBB.2019.2938512","article-title":"Connectivity significance for disease gene prioritization in an expanding universe","volume":"17","author":"Petti","year":"2020","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41388-023-02701-x","article-title":"Functional roles of SRC signaling in pancreatic cancer: recent insights provide novel therapeutic opportunities","volume":"42","author":"Poh","year":"2023","journal-title":"Oncogene"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9170","DOI":"10.3390\/ijms21239170","article-title":"Targeting HGF\/c-MET Axis in pancreatic cancer","volume":"21","author":"Pothula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41467-018-04622-w","article-title":"A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat. Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/healthcare11060887","article-title":"ChatGPT utility in healthcare Education, research, and practice: systematic review on the promising perspectives and valid concerns","volume":"11","author":"Sallam","year":"2023","journal-title":"Healthc. Basel Switz."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1172\/JCI9053","article-title":"Apoptosis and cancer drug targeting","volume":"104","author":"Sellers","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13046-020-1521-4","article-title":"Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK\/MAPK signaling","volume":"39","author":"Sheng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0130589","DOI":"10.1371\/journal.pone.0130589","article-title":"Pathway-dependent effectiveness of network algorithms for gene prioritization","volume":"10","author":"Shim","year":"2015","journal-title":"PLOS ONE"},{"key":"B75","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12094-022-02991-9","article-title":"Tumor-suppressive miR-29c binds to MAPK1 inhibiting the ERK\/MAPK pathway in pancreatic cancer","volume":"25","author":"Si","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1201419","DOI":"10.3389\/fddsv.2023.1201419","article-title":"Drug discovery and development: introduction to the general public and patient groups","volume":"3","author":"Singh","year":"2023","journal-title":"Front. Drug Discov."},{"key":"B78","doi-asserted-by":"publisher","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","article-title":"Mutational landscape of cancer-driver genes across human cancers","volume":"13","author":"Sinkala","year":"2023","journal-title":"Sci. Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1172\/JCI123540","article-title":"Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer","volume":"129","author":"Sivaram","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/molbev\/msz254","article-title":"Improving cancer drug discovery by studying cancer across the tree of life","volume":"37","author":"Somarelli","year":"2019","journal-title":"Mol. Biol. Evol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41232-021-00158-7","article-title":"Genomics-driven drug discovery based on disease-susceptibility genes","volume":"41","author":"Sonehara","year":"2021","journal-title":"Inflamm. Regen."},{"key":"B83","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.3390\/ijms231710132","article-title":"Targeting PI3K\/AKT\/mTOR signaling pathway in pancreatic cancer: from molecular to clinical aspects","volume":"23","author":"Stanciu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","article-title":"Signatures of copy number alterations in human cancer","volume":"606","author":"Steele","year":"2022","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"eabl7895","DOI":"10.1126\/scitranslmed.abl7895","article-title":"Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models","volume":"15","author":"Su","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.3390\/ijms22136923","article-title":"The influence of cell cycle regulation on chemotherapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B88","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"101667","DOI":"10.1016\/j.molmet.2023.101667","article-title":"Islet amyloid polypeptide does not suppress pancreatic cancer","volume":"68","author":"Taylor","year":"2023","journal-title":"Mol. Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","article-title":"Molecular epidemiology and diagnostics of KRAS mutations in human cancer","volume":"39","author":"Timar","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","article-title":"From target discovery to clinical drug development with human genetics","volume":"620","author":"Trajanoska","year":"2023","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e14568","DOI":"10.1111\/cbdd.14568","article-title":"Large language models reshaping molecular biology and drug development","volume":"103","author":"Tripathi","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s43018-021-00258-w","article-title":"TNF-\u03b1-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer","volume":"2","author":"Tu","year":"2021","journal-title":"Nat. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B96","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","article-title":"Applications of single-cell RNA sequencing in drug discovery and development","volume":"22","author":"Van de Sande","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"B97","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2174\/1389200220666191122104955","article-title":"A retrospective look at anti-EGFR agents in pancreatic cancer therapy","volume":"20","author":"Verma","year":"2020","journal-title":"Curr. Drug Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1158\/1078-0432.CCR-04-0779","article-title":"A phase I\/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer","volume":"10","author":"Villalona-Calero","year":"2004","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1399679","DOI":"10.3389\/fmolb.2024.1399679","article-title":"Unraveling metabolic characteristics and clinical implications in gastric cancer through single-cell resolution analysis","volume":"11","author":"Wang","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1038\/s41467-023-38064-w","article-title":"HAPLN1 potentiates peritoneal metastasis in pancreatic cancer","volume":"14","author":"Wiedmann","year":"2023","journal-title":"Nat. Commun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2390\/biecoll-jib-2012-213","article-title":"Network expansion and pathway enrichment analysis towards biologically significant findings from microarrays","volume":"9","author":"Wu","year":"2012","journal-title":"J. Integr. Bioinforma."},{"key":"B103","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbrc.2023.04.080","article-title":"Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1\/EGFR\/AKT\/ERK signaling axis","volume":"664","author":"Wu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13578-023-01118-z","article-title":"Post-translational modification of CDK1\u2013STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties","volume":"13","author":"Xu","year":"2023","journal-title":"Cell Biosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkx1040","article-title":"PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology","volume":"46","author":"Yue","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"W578","DOI":"10.1093\/nar\/gkz428","article-title":"BEERE: a web server for biomedical entity expansion, ranking and explorations","volume":"47","author":"Yue","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"820361","DOI":"10.3389\/fgene.2022.820361","article-title":"PAGER web APP: an interactive, online gene set and network interpretation tool for functional genomics","volume":"13","author":"Yue","year":"2022","journal-title":"Front. Genet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.intonc.2025.06.004","article-title":"AI-driven network biology identifies SRC as a therapeutic target in metastatic pancreatic adenocarcinoma","volume":"1","author":"Zhang","year":"2025","journal-title":"Intell. Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e31507","DOI":"10.1371\/journal.pone.0031507","article-title":"DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/1078-0432.CCR-13-0209","article-title":"Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"bbab006","DOI":"10.1093\/bib\/bbab006","article-title":"Benchmarking network-based gene prioritization methods for cerebral small vessel disease","volume":"22","author":"Zhang","year":"2021","journal-title":"Brief. Bioinform."},{"key":"B112","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41467-024-49105-3","article-title":"ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"B113","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/molecules22020279","article-title":"Drug design and discovery: principles and applications","volume":"22","author":"Zhou","year":"2017","journal-title":"Molecules"},{"key":"B114","doi-asserted-by":"publisher","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"693538","DOI":"10.3389\/fgene.2021.693538","article-title":"Structure and function of pancreatic lipase-related protein 2 and its relationship with pathological states","volume":"12","author":"Zhu","year":"","journal-title":"Front. Genet."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.21037\/atm-21-1948","article-title":"A narrative review of tumor heterogeneity and challenges to tumor drug therapy","volume":"9","author":"Zhu","year":"","journal-title":"Ann. Transl. Med."}],"container-title":["Frontiers in Systems Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2025.1649758\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:14:13Z","timestamp":1759119253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2025.1649758\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":116,"alternative-id":["10.3389\/fsysb.2025.1649758"],"URL":"https:\/\/doi.org\/10.3389\/fsysb.2025.1649758","relation":{},"ISSN":["2674-0702"],"issn-type":[{"value":"2674-0702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1649758"}}